Patents
US 11440970 B2: Nicotine-binding antibodies
- Granted
- 2022-09-13
- Filed
- 2018-08-14 application 16639050
- Type
- Utility · 18 claims
- Elsewhere
- Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗
Abstract
Described are novel nicotine-binding antibodies and methods of using them for treating nicotine addiction and/or facilitating smoking cessation, or for treating nicotine overdose or nicotine poisoning.
Source: PVGPATDIS, file of 2026-04-10 (ipg220913.xml).
Assignees
| Assignee | Type | Place | Also on furp.org | Source |
|---|---|---|---|---|
| ANTIDOTE THERAPEUTICS, INC. 3 patents | US company or organization | Bethesda, MD | Antidote Therapeutics, Inc. Form D issuer EXACT high confidence: identical full name and state | PVGPATDIS, file of 2026-04-10 |
| BliNK BIOMEDICAL 1 patents | Foreign company or organization | Marseilles, FR | PVGPATDIS, file of 2026-04-10 | |
| Hennepin Healthcare Research Institute 3 patents | US company or organization | Minneapolis, MN | HENNEPIN HEALTHCARE RESEARCH INSTITUTE Nonprofit EXACT high confidence: identical full name and state | PVGPATDIS, file of 2026-04-10 |
Inventors
| Inventor | Place | Patents | Person page | Source |
|---|---|---|---|---|
| Matthew W. KALNIK | Gaithersburg, MD | 4 | PVGPATDIS, file of 2026-04-10 | |
| Thomas Thisted | Gaithersburg, MD | 28 | PVGPATDIS, file of 2026-04-10 | |
| Nicola Beltraminelli | Marseilles, FR | 7 | PVGPATDIS, file of 2026-04-10 | |
| Stéphanie Fallot | Marseilles, FR | 4 | PVGPATDIS, file of 2026-04-10 | |
| Zuzana Biesova | Bethesda, MD | 4 | PVGPATDIS, file of 2026-04-10 | |
| Steve Fuller | Bethesda, MD | 2 | PVGPATDIS, file of 2026-04-10 | |
| Mark G. Lesage | Minneapolis, MN | 1 | PVGPATDIS, file of 2026-04-10 | |
| Paul Pentel | Minneapolis, MN | 1 | PVGPATDIS, file of 2026-04-10 |
CPC categories
| Subclass | Category | First group | Source |
|---|---|---|---|
| C07K | Peptides | C07K16/44 | PVGPATDIS, file of 2026-04-10 |
| A61K | Preparations for medical, dental or toiletry purposes | A61K9/0019 | PVGPATDIS, file of 2026-04-10 |
| A61P | Specific therapeutic activity of chemical compounds or medicinal preparations | A61P25/34 | PVGPATDIS, file of 2026-04-10 |
Cooperative Patent Classification, as currently assigned (one row per subclass).
Assignments and security interests
| Recorded | What | From | To | Reel/frame | Source |
|---|---|---|---|---|---|
| 2020-09-02 | Assignment Assignment of assignor's interest | LESAGE, MARK G. signed 2018-08-09 PENTEL, PAUL signed 2018-08-09 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE MINNEAPOLIS,, MN | 53671/972 | ECORSEXC, file of 2026-09-25 |
| 2020-09-02 | Assignment Assignment of assignor's interest | FULLER, STEVE signed 2018-08-09 BIESOVA, ZUZANA signed 2018-08-10 KALNIK, MATTHEW W. signed 2018-08-10 THISTED, THOMAS signed 2018-08-10 | ANTIDOTE THERAPEUTICS, INC. GAITHERSBURG, MD | 53671/964 | ECORSEXC, file of 2026-09-25 |
| 2020-09-02 | Assignment Assignment of assignor's interest | BELTRAMINELLI, NICOLA signed 2018-08-30 FALLOT, STÉPHANIE signed 2018-09-09 | BLINK BIOMEDICAL MARSEILLE | 53671/767 | ECORSEXC, file of 2026-09-25 |
Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.
USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.